- Home
- GFAI vs ELEV Comparison
GFAI vs ELEV Comparison
Compare GFAI & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- ELEV
- Stock Information
- Founded
- GFAI 2018
- ELEV 2019
- Country
- GFAI Singapore
- ELEV United States
- Employees
- GFAI N/A
- ELEV N/A
- Industry
- GFAI Diversified Commercial Services
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- GFAI Consumer Discretionary
- ELEV Health Care
- Exchange
- GFAI Nasdaq
- ELEV Nasdaq
- Market Cap
- GFAI 20.7M
- ELEV 20.0M
- IPO Year
- GFAI N/A
- ELEV 2021
- Fundamental
- Price
- GFAI $1.15
- ELEV $0.30
- Analyst Decision
- GFAI Strong Buy
- ELEV Buy
- Analyst Count
- GFAI 1
- ELEV 6
- Target Price
- GFAI $4.50
- ELEV $2.94
- AVG Volume (30 Days)
- GFAI 367.3K
- ELEV 816.1K
- Earning Date
- GFAI 04-28-2025
- ELEV 05-15-2025
- Dividend Yield
- GFAI N/A
- ELEV N/A
- EPS Growth
- GFAI N/A
- ELEV N/A
- EPS
- GFAI N/A
- ELEV N/A
- Revenue
- GFAI $36,347,373.00
- ELEV N/A
- Revenue This Year
- GFAI $5.66
- ELEV N/A
- Revenue Next Year
- GFAI $4.69
- ELEV N/A
- P/E Ratio
- GFAI N/A
- ELEV N/A
- Revenue Growth
- GFAI 0.18
- ELEV N/A
- 52 Week Low
- GFAI $0.76
- ELEV $0.22
- 52 Week High
- GFAI $3.88
- ELEV $4.33
- Technical
- Relative Strength Index (RSI)
- GFAI 53.79
- ELEV 42.49
- Support Level
- GFAI $1.11
- ELEV $0.30
- Resistance Level
- GFAI $1.33
- ELEV $0.32
- Average True Range (ATR)
- GFAI 0.08
- ELEV 0.03
- MACD
- GFAI 0.01
- ELEV -0.00
- Stochastic Oscillator
- GFAI 37.93
- ELEV 28.67
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.